Health Care/Hospital

RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome

YANTAI, China, April 3, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, obtained Fast Track Designation (FTD) by the United States Food and Drug Administration (FDA) recently for its inno...

2024-04-03 11:14 1515

Samyang Holdings's Croquis® Shows New Clinical Cases of PDO thread lift at AMWC 2024

* Sharing Clinical Cases of "Croquis® at AMWC 2024 in Monaco. * Expand market with proven safety and efficacy, 29 countries worldwide.  * "Croquis®" Lifting Threads with Samyang' 25 years Expertise in Global Biodegradable Suture Threads. SEOUL, South Korea, April 3, 2024 /PRNewswire/ -- Samy...

2024-04-03 09:30 1819

Value innovations address health concerns amid rising costs

AUCKLAND, New Zealand, April 3, 2024 /PRNewswire/ -- Four in 10 consumers worldwide find health and wellbeing nutritional products too expensive, with one-third of users saying that rising costs have made it hard to continue purchasing them. Despite feeling the pinch, health and wellbeing still ...

2024-04-03 09:23 1422

Latvian pharmaceutical manufacturing company Grindeks opens new subsidiaries worldwide

RIGA, Latvia, April 3, 2024 /PRNewswire/ -- The leading pharmaceutical company in the Baltics, Grindeks, is developing new products and reinforcing its position not only in European but also global markets. With determination and innovative approaches, Grindeks continues to enhance the competitiv...

2024-04-03 05:00 1760

TraceLink Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024

TraceLink joins the ranks of Nvidia, YouTube, OpenAI, Novo Nordisk and more BOSTON, April 3, 2024 /PRNewswire/ -- TraceLink has been named to Fast Company 's prestigious list of the World's Most Innovative Companies of 2024. This year's list shines a spotlight on businesses that are shaping their...

2024-04-03 03:22 1414

LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development

SHENZHEN, China, April 2, 2024 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech", Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiarie...

2024-04-02 22:13 3485

Cognex Launches the World's First 3D Vision System with AI

AI-powered 3D vision system offers fast deployment and reliable inspections for manufacturing automation NATICK, Mass., April 2, 2024 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the leader in industrial machine vision, today released the In-Sight® L38 3D Vision System, which combines AI, ...

2024-04-02 20:30 2048

CONCEPT MEDICAL RECEIVES US FDA IDE APPROVAL FOR MAGICTOUCH AVF INDICATION, THEIR FIFTH US CLINICAL STUDY APPROVAL FOR THE MAGICTOUCH PORTFOLIO

TAMPA, Fla., April 2, 2024 /PRNewswire/ -- Concept Medical has been granted 'IDE Approval' from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, to initiate a clinical study for the treatment of stenotic lesions of Arteriovenous Fis...

2024-04-02 17:33 2052

Grown Alchemist Completes Change of Ownership

The beauty brand moves to privately held ownership to accelerate growth and drive development in key markets includingNorth America and China HONG KONG, April 2, 2024 /PRNewswire/ -- Grown Alchemist , an award-winning biological beauty brand for the design conscious,...

2024-04-02 16:01 1469

AXA launches IncomeBliss Qualifying Deferred Annuity Policy

Empowering retirement planning with dementia advance benefits and the flexibility to choose between cash payouts or reinvestment of annuities Successful applicants can enjoy exclusive subscription to the 5-Year GoalSaver with up to 4.8% p.a. guaranteed returns upon maturity[1] HONG KONG, April 2...

2024-04-02 15:17 1367

European Wellness Shines at AMWC 2024 in Monaco, with Prof. Dr Mike Chan and Prof. Dr Roni Moya as Faculty's Stem Cells Speakers

MONTE CARLO, Monaco, April 2, 2024 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG), a global pioneer in biotechnology and bioregenerative medicine, is pleased to announce its extraordinary participation in the 22nd Aesthetic & Anti-Ageing Medicine World Congress (AMWC) 2024, which w...

2024-04-02 14:16 1602

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status

ROCKVILLE, Md. and SUZHOU, China, April 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune,...

2024-04-02 13:00 1820

Moneymax partners with FWD Life Insurance to empower Filipinos in making better financial decisions

FWD Life Insurance's diverse portfolio of insurance products are now available on Moneymax for easy purchase MANILA, Philippines, April 2, 2024 /PRNewswire/ -- Moneymax, the Philippines' largest personal finance marketplace for financial products and a subsidiary of MoneyHero Limited

2024-04-02 11:54 2885

Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY

HONG KONG and SHANGHAI, April 2, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today announced its annual results for the year ended31 December 2023 (the "Reporting Period"). During the R...

2024-04-02 11:31 2949

Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS

Pioneering biologics CDMO rapidly adopts Veeva Vault QMS to advance development and manufacturing operations BANGALORE, India, April 2, 2024 /PRNewswire/ -- Veeva Systems  (NYSE: VEEV) today announced that Kemwell BioPharma, India's largest biologics contract developmen...

2024-04-02 10:30 1580

InsureMO partners with MoneyHero Group to create the premiere digital insurance aggregation and comparison platform in Greater Southeast Asia

SINGAPORE, April 2, 2024 /PRNewswire/ -- InsureMO is thrilled to announce its strategic partnership with MoneyHero Limited (NASDAQ: MNY) to create the premiere digital insurance aggregation and comparison platform inGreater Southeast Asia. InsureMO's cutting-edge middleware platform has been s...

2024-04-02 10:00 2954

Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023

Increase in the number of patients treated and gains in operational efficiency explain record results SÃO PAULO, April 2, 2024 /PRNewswire/ -- Oncoclínicas&Co (B3: ONCO3) – the largest group dedicated to cancer treatment inLatin America – reported a 35.1% growth in its gross revenue in 2023, tot...

2024-04-02 00:38 1575

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

TOKYO, April 1, 2024 /PRNewswire/ -- ThinkCyte today announced the publication of apaper in the March issue of Cell Reports Methods on a new method for high-throughput drug discovery. Together with a joint research group including investigators at theUniversity of Tokyo and the University of Brit...

2024-04-01 21:00 1683

Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development

PROVIDENCE, R.I., April 1, 2024 /PRNewswire/ -- In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk – a critical characterization step in the candidate dev...

2024-04-01 20:00 1935

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

HONG KONG, April 1, 2024 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced unaudited financial results for the fourth quarter and full year endedDecember 31, 2023, along with recent business up...

2024-04-01 19:30 2536
12345678 ... 552